Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 390

1.

Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.

Bordás P, Jonsson H, Nyström L, Lenner P.

J Med Screen. 2009;16(1):39-45. doi: 10.1258/jms.2009.008098.

PMID:
19349530
2.

Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.

Taylor R, Page A, Bampton D, Estoesta J, Rickard M.

J Med Screen. 2004;11(4):199-206.

PMID:
15563775
4.

Mammography screening in the county of Fyn. November 1993-December 1999.

Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, Graversen HP, Schwartz W, Lynge E.

APMIS Suppl. 2003;(110):1-33.

PMID:
12739252
5.

Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland.

Anttila A, Koskela J, Hakama M.

J Med Screen. 2002;9(4):153-8.

PMID:
12518004
6.

Monitoring interval cancers in an Australian mammographic screening programme.

Kavanagh AM, Mitchell H, Farrugia H, Giles GG.

J Med Screen. 1999;6(3):139-43.

PMID:
10572844
7.

Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.

Jonsson H, Bordás P, Wallin H, Nyström L, Lenner P.

J Med Screen. 2007;14(2):87-93.

PMID:
17626708
8.

Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.

Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A.

J Med Screen. 1995;2(2):94-8.

PMID:
7497163
9.

Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.

Hellquist BN, Duffy SW, Nyström L, Jonsson H.

J Med Screen. 2012 Mar;19(1):14-9. doi: 10.1258/jms.2012.011104. Epub 2012 Feb 21.

PMID:
22355181
10.

The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.

Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Erikson O, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Säwe-Söderberg J.

J Natl Cancer Inst Monogr. 1997;(22):53-5.

PMID:
9709276
11.

Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.

Otten JD, van Dijck JA, Peer PG, Straatman H, Verbeek AL, Mravunac M, Hendriks JH, Holland R.

J Epidemiol Community Health. 1996 Jun;50(3):353-8.

12.

The natural history of invasive breast cancers detected by screening mammography.

Zahl PH, Maehlen J, Welch HG.

Arch Intern Med. 2008 Nov 24;168(21):2311-6. doi: 10.1001/archinte.168.21.2311.

PMID:
19029493
13.

Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.

Jonsson H, Nyström L, Törnberg S, Lenner P.

J Med Screen. 2001;8(3):152-60.

PMID:
11678556
14.

The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.

Waller M, Moss S, Watson J, Møller H.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2257-61.

15.
16.
17.
18.

Results from 10 years of breast screening in Wales.

Fielder H, Rogers C, Gower-Thomas K, Monypenny I, Dallimore N, Brook D, Greening S.

J Med Screen. 2001;8(1):21-3.

PMID:
11373845
19.

[Mammography screening in the county of Copenhagen. Results of the first three screening rounds].

Tange UB, Hirsch FR, Jensen MB, Olsen AH, Blichert-Toft M, Rank FE, Vejborg IM, Mouridsen H, Lynge E.

Ugeskr Laeger. 2002 Feb 18;164(8):1048-52. Danish.

PMID:
11894707
20.

Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.

Coldman AJ, Phillips N, Olivotto IA, Gordon P, Warren L, Kan L.

J Med Screen. 2008;15(4):182-7. doi: 10.1258/jms.2008.008064.

PMID:
19106258
Items per page

Supplemental Content

Write to the Help Desk